4A4B11細(xì)胞

ATCC Number： HB-8327?

運輸方式： 凍存運輸

是否是腫瘤細(xì)胞： 0

物種來源： 小鼠

數(shù)量： 大量

細(xì)胞形態(tài)： **樣

**類型： IgG

生長狀態(tài)： 懸浮生長

Designations: 4A4B11

Depositors: Immunomedics, Inc.

4A4B11細(xì)胞Isotype: IgG

Biosafety Level: 1

Shipped: frozen

Medium & Serum: See Propagation

Growth Properties: suspension

Organism: Mus musculus (B cell); Mus musculus (myeloma)

Morphology: lymphoblast

Source: Cell Type: hybridoma: B lymphocyte;

Cellular Products: immunoglobulin; monoclonal antibody; against human complement C1q

Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.

4A4B11細(xì)胞Tumorigenic: Yes

Comments: Animals were immunized with purified human C1q.

Spleen cells were fused with Sp2/0-Ag14 myeloma cells.

Propagation: ATCC complete growth medium: RPMI 1640 medium with 0.1 mM hypoxanthine and 0.016 mM thymidine, 90%; fetal bovine serum, 10%

Subculturing: Medium Renewal: Every 2 to 3 days

Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.

References: 3547: Reckel RP, et al. Method for detecting immune complexes in serum. 4A4B11細(xì)胞US Patent 4,595,654 dated Jun 17 1986